BACE1 and Alzheimer disease: In the brain of an aged AD rabbit model, berberine also reduces the BACE1 activity, thereby clearing the Aβ deposition, concurrent with improvement in the behavioral symptoms, such as head-tilting, tremor, weight loss, and paralysis [26,27].